Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-008126

EVP, CFO & Treasurer sold 3,947 shares at $9.86 ($38,925)

From the SEC's structured data for this filing

Trades in this filing

Mason Michael · EVP, CFO & Treasurer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-07 Sale : show line 1 in the form −3,947 $9.86 $38,925 53,308 D
Open-market sales · 3,947 sh · avg $9.86 · $38,925
Loading xslF345X03/doc4.xml…